Document:

Exhibit
4.2

FIRST
SUPPLEMENTAL INDENTURE

TO INDENTURE DATED OCTOBER 15, 2004

This First Supplemental
Indenture, dated as of October 5, 2006 (the “Supplemental Indenture”), among
Heritage Property Investment Trust, Inc., a Maryland corporation (the “Company”),
Centro Saturn MergerSub LLC, a Delaware limited liability company (the “Successor”)
and LaSalle Bank National Association, as trustee (the “Trustee”).

WHEREAS, the Company, the
Trustee, Heritage Property Investment Limited Partnership, a Delaware limited
partnership and Bradley Operating Limited Partnership, a Delaware limited
partnership, as guarantors, are parties to the Indenture, dated as of October
15, 2004 (the “Indenture”), governing the Company’s 4.50% Notes due 2009 (the “Notes”)
(Capitalized terms used but not defined in this Supplemental Indenture shall
have the meanings given them in the Indenture);

WHEREAS, the Company,
Centro Saturn LLC, a Delaware limited liability company and the Successor have
entered into an Agreement and Plan of Merger, dated as of July 9, 2006,
pursuant to which the Company will merge with and into the Successor (the “Merger”),
with the Successor as the surviving entity in the Merger and as a result of
which the separate existence of the Company shall cease and the Successor will
succeed to and possess all of the rights, privileges, powers and franchises of
the Company and will be subject to all of the restrictions, disabilities and
duties of the Company, as provided under the General Corporation Law of the
State of Delaware;

WHEREAS, Section 5.01 of
the Indenture provides, among other things, that the Company may merge with or
into any other entity, provided that the successor entity expressly assumes by
supplemental indenture complying with Article 9 of the Indenture the due and
punctual payment of the principal of, premium, if any, and any interest on all
of the Notes according to their tenor, and the due and punctual performance and
observance of all of the covenants and conditions of the Indenture to be
performed by the Company;

WHEREAS, Section 9.01(a)
of the Indenture provides, among other things, that the Company and the Trustee
may amend or supplement the Indenture or the Notes without the consent of any
Holder of a Note to evidence the succession of another Person to the Company
and the assumption by any such successor of the covenants of the Company in the
Indenture and the Notes;

WHEREAS, Section 9.01(i)
of the Indenture provides that the Company and the Trustee may amend or
supplement the Indenture or the Notes without the consent of any Holder of a
Note to, among other things, correct or supplement any provision in the
Indenture which may be defective or inconsistent with any other provision
therein, provided that such provisions shall not adversely affect the interests
of any of the Holders in any material respect;

 

 

WHEREAS, there exists an
inconsistency (the “Inconsistency”) between (a) Section 5.01 of the Indenture
in which the phrase “successor entity” is used to refer to the entity, among
other things, that the Company may merger with or into pursuant to Section 5.01
and (b) each of the following provisions of the Indenture in which the phrase “successor
corporation” is incorrectly used to refer to the entity, among other things,
that the Company may merger with or into pursuant to Section 5.01: (i) clause
(8) of the definition of “Consolidated Net Income,” (ii) Section 5.02 of the
Indenture and (iii) Section 5.03 of the Indenture;

WHEREAS, the Company and
the Successor have been authorized by resolutions of their respective board of
directors or similar governing body to enter into this Supplemental Indenture;
and

WHEREAS, all acts,
conditions, proceedings and requirements necessary to make this Supplemental
Indenture a valid, binding and legal agreement enforceable in accordance with
its terms for the purposes expressed herein, in accordance with its terms, have
been duly complied with and performed.

NOW, THEREFORE, in
consideration of the premises and the covenants and agreements contained
herein, and for other good and valuable consideration the receipt of which is
hereby acknowledged, the Company, the Successor and the Trustee hereby agree as
follows:

ARTICLE I

REPRESENTATIONS
OF THE COMPANY AND THE SUCCESSOR

        
1.1.     The Company represents
and warrants to the Trustee as follows:

        
(a)      The Company is a
corporation duly organized, validly existing and in good standing under the
laws of the State of Delaware.

        
(b)      The execution, delivery
and performance by the Company of this Supplemental  Indenture have been authorized and approved
by all necessary corporate action on its part.

        
1.2.     The Successor represents
and warrants to the Trustee as follows:

        
(a)      The Successor is a
limited  liability company duly
organized, validly existing and in good standing under the laws of the State of
Delaware.

        
(b)      The execution, delivery
and  performance by the Successor of this
Supplemental Indenture have been authorized and approved by all necessary limited
liability company action on its part.

 

 

ARTICLE
II

ASSUMPTION

        
2.1.     Pursuant to Section 5.01
of the Indenture, upon the effective time of the Merger, the Successor hereby
expressly assumes the due and punctual payment of the principal of, premium, if
any, and any interest on all of the Notes according to their tenor, and the due
and punctual performance and observance of all of the covenants and conditions
of the Indenture to be performed by the Company.

        
2.2.     Pursuant to Section 5.02
of the  Indenture, upon the effective
time of the Merger, the Successor shall succeed to and be substituted for the
Company with the same effect as if the Successor had been named in the
Indenture as the party of the first part, and the Company shall be relieved of
any further obligation under the Indenture and the Notes.

ARTICLE
III

AMENDMENTS

        
3.1.     Pursuant to Section
9.01(i) of the Indenture and in order to correct the Inconsistency, each of (i)
clause (8) of the definition of “Consolidated Net Income,” (ii) Section 5.02 of
the Indenture and (iii) Section 5.03 of the Indenture, is hereby amended such
that each occurrence of the phrase “successor corporation” therein is hereby
replaced with the phrase “successor entity”.

        
3.2.     The addresses for notices
set forth in Section 12.02 of the Indenture for the Company and the Guarantors
is hereby amended to read:

Centro Saturn LLC

c/o Centro Properties Group

Corporate Offices 3rd Floor

The Glen Shopping Centre

235 Springvale Road

Glen Waverly Victoria, Australia 3150

Attention:   Andrew Scott
                     John
Hutchinson

Telecopier No: 011-61-3-9886-1345

with a copy to:

Skadden, Arps, Slate, Meagher & Flom LLP

Four Times Square

New York, NY 10036-6522

Telecopier No: (212) 735-2000

Attention: Alan C. Myers, Esq.

 

 

        
3.3.     Except as amended hereby,
the Indenture, the Notes and the Guarantees of the Notes are in all respects
ratified and confirmed and all the terms thereof shall remain in full force and
effect and the Indenture, as so amended by this Supplemental Indenture, shall
be read, taken and construed as one and the same instrument.

ARTICLE
IV

MISCELLANEOUS

        
4.1.     This Supplemental
Indenture shall become effective as of the effective time of the Merger.

        
4.2.     The law of the State of
New York shall govern and be used to construe this Supplemental Indenture.

        
4.3.     The parties may sign any
number of copies of this Supplemental Indenture. Each signed copy shall be an
original, but all of them together represent the same agreement.

        
4.4.     The Article headings
herein are for convenience only and shall not affect the construction hereof.

        
4.5.     If any provision of this
Supplemental Indenture limits, qualifies or conflicts with any provision of the
Trust  Indenture Act that may not be so
limited, qualified or conflicted with, such provision of such Act shall
control.  If any provision of this  Supplemental Indenture modifies or excludes
any provision of the Trust  Indenture Act
that may be so modified or excluded, the provision of such Act shall be deemed
to apply to the Indenture as so modified or to be excluded by this Supplemental
Indenture, as the case may be.

        
4.6.     In case any provision in
this Supplemental  Indenture shall be
invalid, illegal  or unenforceable, the
validity, legality and enforceability of the remaining provisions shall not in
any way be affected or impaired thereby.

        
4.7.     Nothing in this
Supplemental Indenture, the Indenture or the Notes, express or implied, shall
give to any person, other than the parties hereto and thereto and their  successors hereunder and thereunder and the
Holders of Notes, any benefit of any legal or equitable right, remedy or claim
under the Indenture, this Supplemental Indenture or the Notes.

 

 

         IN
WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to
be duly executed, all as of the date first above written.

	
  CENTRO SATURN MERGERSUB LLC

  
	
   

  	
   

  
	
  By:

  	
  Centro Saturn LLC, as sole member

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  By

  	
  /s/BASIL S. DONNELLY

  
	
   

  	
  Name: Basil S.
  Donnelly

  
	
   

  	
  Title: Vice
  President

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  HERITAGE PROPERTY INVESTMENT TRUST, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
  By

  	
  /s/ STEPHEN H.
  FABERMAN

  
	
   

  	
  Name: Stephen H. Faberman

  
	
   

  	
  Title: Vice President and Secretary

  
	
   

  	
   

  
	
   

  	
   

  
	
  LASALLE BANK NATIONAL ASSOCIATION, AS TRUSTEE

  
	
   

  	
   

  
	
   

  	
   

  
	
  By 

  	
  /s/ VICTORIA
  Y. DOUYON

  
	
   

  	
  Title: First Vice PresidentExhibit 4.7

 

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON ITS EXERCISE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES OR BLUE
SKY LAW, AND MAY NOT BE SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT, OR AN EXEMPTION FROM REGISTRATION, THEREUNDER.

 

GENUTEC
BUSINESS SOLUTIONS, INC.

 

Common
Stock Purchase Warrant

 

GenuTec Business Solutions, Inc., a Montana
corporation (the “Company”), hereby certifies
that, for value received, SEAVIEW
MEZZANINE FUND LP, a Delaware limited partnership, or its registered
assigns (the “Holder”), is entitled,
subject to the terms set forth below, to purchase from the Company, at any time
and from time to time during the period beginning on the date hereof and ending
on September 16, 2010 (the “Expiration Date”),
in whole or in part, an aggregate of Two Hundred Ninety-One Thousand Seven
Hundred Fifty (291,750) fully paid and non-assessable shares of the Class A
Voting Common Stock, par value $.01 per share, of the Company (“Common Stock”), subject to certain
adjustments pursuant to Section 3 hereof (the “Warrant
Shares”), at an initial exercise price of Two Dollars ($2.00)
per share, subject to certain adjustments pursuant to Section 3 hereof
(the “Exercise Price”).  This warrant is one of the warrants (collectively,
“Warrants” and each individually a “Warrant”) issued or to be issued
pursuant to the provisions of the Preferred Stock and Warrant Purchase
Agreement dated as of September 16, 2005 by and among the Company and the
Purchasers named therein (the “Stock Purchase Agreement”),
or the Note Purchase Agreement (as defined in the Stock Purchase Agreement).  Capitalized terms used herein and not
otherwise defined herein shall have the meanings ascribed to such terms in the Stock
Purchase Agreement.

 

1.                                       EXERCISE OF
WARRANT.

 

1.1                                 Method
of Exercise.  The purchase rights
evidenced by this warrant (this “Warrant”)
shall be exercised by the Holder surrendering this Warrant, with the form of
subscription at the end hereof duly executed by the Holder, to the Company at its principal office at 6A Liberty
Street, Suite 200, Aliso Viejo, CA  92656, or such other office
or agency of the Company as the Company may hereafter designate for such
purposes by written notice to the Holder (the “Principal
Office”), accompanied by payment of an amount (the “Exercise Payment”) equal to the
Exercise Price multiplied by the number of shares being purchased pursuant to
such exercise, payable as follows:  (a) by payment to the Company in cash, by certified or official bank check, or
by wire transfer of the Exercise Payment, (b) by surrender to the Company
for cancellation of securities of the Company having a Market Price (as defined
below) on the date of exercise equal to the Exercise Payment; or (c) by a
combination of the methods described in clauses (a) and (b) above.  In lieu of exercising this Warrant in the
foregoing manner, the Holder may elect to receive upon such exercise (and
without payment to the Company of any Exercise Payment), a number of newly
issued shares of Common Stock having an aggregate Market Price per share as of
the date this Warrant is so exercised equal to

 

 

the product of (A) the number of Warrant Shares for which this
Warrant is then being exercised, multiplied by (B) the difference (not
less than zero) between (i) the Market Price per share of Common Stock as
of such date and (ii) the Exercise Price per share of Common Stock as of
such date (hereinafter referred to as a “Cashless Exercise”).

 

1.2                                 Market
Price.  As used in this Warrant,
the term “Market Price”
shall mean, as of any date of determination, with respect to the Common Stock
or any other securities, (A) if the Common Stock or such other securities (as
the case may be) are listed or admitted to trading on any national securities
exchange, the average of the last reported sale prices, regular way, per share
of Common Stock or other securities (as the case may be) for each of the 20
consecutive trading days preceding such day on the principal national
securities exchange on which the shares of Common Stock or other
securities (as the case may be) are listed or admitted to trading
(without taking into account any extended or after-hours trading session), or (B) if the Common Stock or such other securities (as
the case may be) are not listed or admitted to trading on any national
securities exchange but are listed on The Nasdaq Stock Market, Inc. (“Nasdaq”) or quoted in the Over-the-Counter
Bulletin Board (the “OTC Bulletin Board”)
of the National Association of Securities Dealers, Inc. (“NASD”), the average of the last
reported sale prices (or, if last-sale price quotations are not available, the
average of the last available bid and asked prices) per share of
Common Stock or other securities (as the case may be) for each of the days in
such 20 trading day period as reported on Nasdaq or the OTC Bulletin Board (without
taking into account any extended or after-hours trading session), or (C) if the Common Stock or such other securities (as
the case may be) are traded in the over-the-counter market but not quoted on the OTC Bulletin Board, the average of the last available
bid and asked prices per share of the Common Stock or other
securities (as the case may be) for each of the days in such 20 trading day
period as quoted in the Pink Sheets Electronic Quotation Service or, if not so
quoted, as furnished by any member of the NASD selected by the Company, or (D) if
the Common Stock or such other securities (as the case may be) are not publicly
traded, the Market Price for such day shall be the fair market value per share thereof
as determined jointly by the Company and the holders of Warrants
exercisable to purchase a majority of the shares of Common Stock which may be
purchased upon exercise of all of the outstanding Warrants (the “Majority Holders”); provided,
however, that if such parties are unable to reach agreement within a
period of 15 days, the Market Price shall be determined in good faith by an
independent investment banking firm selected jointly by the Company and the Majority
Holders, or, if that selection cannot be made within 15 days, by an independent
investment banking firm selected by the American Arbitration Association in
accordance with its rules.  The fees and expenses of such independent investment banking firm shall be
borne 50% by the Company and 50% by the holders of Warrants (pro rata in
accordance with the respective numbers of shares of Common Stock for which such
Warrants are exercisable).  For
the purposes hereof, the determination of the “fair market value” of any shares
of Common Stock shall be based upon the market value of the Company determined
on a going concern basis, assuming that all of the outstanding shares of Common
Stock of the Company are being sold as between a willing buyer and a willing
seller in an arm’s length transaction for cash payable in full on completion,
and that all Indebtedness of the Company and its subsidiaries shall have been
paid and satisfied in full on the relevant date, and taking into account any
shares of any class which may be issuable under any then outstanding options,
warrants or other rights to subscribe for, or securities convertible into or
exchangeable for, shares of Common Stock, and taking into account all other
relevant factors determinative of value, provided that no discount shall
be imposed by reason of such shares of Common Stock

 

2

 

constituting a minority ownership interest or by reason of the
illiquidity of such shares or any contractual or other restrictions on the sale
or transfer thereof.  Notwithstanding the
foregoing, if this Warrant is being exercised in connection with a public
offering of Common Stock, Market Price shall mean the initial public offering
price per share in such offering.

 

1.3                                 Partial
Exercise.  This Warrant may be
exercised for less than the full number of Warrant Shares, in which case the number of
shares receivable upon the exercise of this Warrant as a whole, and the sum
payable upon the exercise of this Warrant as a whole, shall be proportionately
reduced.  Upon any such partial exercise,
the Company at its expense will forthwith issue to the Holder a new Warrant or
Warrants of like tenor calling for the number of shares of Common Stock as to which rights have not been exercised, such Warrant or
Warrants to be issued in the name of the Holder hereof or his or its nominee
(upon payment by the Holder of any applicable transfer taxes).

 

2.                                       DELIVERY OF
STOCK CERTIFICATES ON EXERCISE.  As soon as practicable after the
exercise of this Warrant and payment of the Exercise Payment (or exercise
hereof pursuant to a Cashless Exercise), and in any event within ten (10) days thereafter, the Company, at its expense, will cause to be
issued in the name of and delivered to the Holder a certificate or certificates
for the number of fully paid and non-assessable shares of Common Stock or other
securities or property to which the Holder shall be entitled upon such
exercise, plus, in lieu of any fractional share to which the Holder would
otherwise be entitled, cash in an amount determined in accordance with Section 3.8
hereof.  The Company agrees that the
shares of Common Stock so purchased shall be deemed to be issued to the Holder
as the record owner of such shares as of the close of business on the date on
which this Warrant shall have been surrendered and payment made for such shares
as aforesaid.

 

3.                                       ADJUSTMENTS.  The number of Warrant Shares and the Exercise Price shall be subject to
adjustment from time to time in accordance with this Section 3.  Upon each adjustment of number of Warrant
Shares pursuant to this Section 3, the registered Holder of this Warrant
shall thereafter be entitled to acquire upon exercise, at the Exercise Price,
the adjusted number of Warrant Shares.

 

3.1                                 Adjustment
for Issue or Sale of Common Stock at Less than the Trigger Price.  Except as provided in Section 3.2 or 3.5
below, if and whenever on or after the date of issuance hereof the Company
shall issue or sell, or shall in accordance with subsections 3.1(1) to
(9), inclusive, be deemed to have issued or sold, any shares of Common Stock
for a consideration per share of less than the greater of (a) the Market
Price per share of Common Stock as of the date of such issuance or sale or (b) $2.00
per share (such amount being herein called the “Trigger
Price” and such transaction being called the “Triggering Transaction”), then
forthwith upon such Triggering Transaction, the number of Warrant Shares shall,
subject to subsections (1) to (9) of this Section 3.1, be
increased to the number of Warrant Shares (calculated to the nearest whole
share of Common Stock) determined as follows:

 

W’ = W
+ [N – (P x N  ̧ T)] x W  ̧ [O + (P x N  ̧ T)]

1 – {W  ̧ [O + (P x N  ̧ T)]}

 

As used in the foregoing formula:

 

3

 

O =                             the
number of shares of Common Stock Outstanding on a Fully Diluted Basis immediately
prior to the Triggering Transaction.

 

T =                              the
Trigger Price.

 

W =                         the
number of Warrant Shares immediately prior to the Triggering Transaction.

 

N =                             the
number of new shares of Common Stock issued or deemed issued in connection with
the Triggering Transaction.

 

P =                               the
aggregate consideration and deemed consideration paid per share of Common Stock
issued or issuable as a result of the Triggering Transaction (the “Purchase Price”).

 

W’ =                     the adjusted
number of Warrant Shares pursuant to this Section 3.

 

By way of example, if (i) the Company
has 1,000,000 shares of Common Stock Outstanding on a Fully Diluted Basis,
immediately prior to the Triggering Transaction (O=1,000,000), (ii) the
number of Warrant Shares immediately prior to the Triggering Transaction is
20,000 (W=20,000), (iii) the Trigger Price is $12.00 (T=12.00), (iv) the
price per share paid for the newly issued shares of Common Stock is $9.00
(P=$9.00) and (v) the number of new shares to be issued or deemed issued
by the Company in connection with the Triggering Transaction is 100,000
(N=100,000), the adjusted number of Warrant Shares would be calculated as
follows:

 

W’ = 20,000 + [100,000 – (9.00 x 100,000  ̧
12.00)] x 20,000  ̧ [1,000,000 + (9.00
x 100,000  ̧ 12.00)] 
= 20,474

1 – {20,000  ̧
[1,000,000 + (9.00 x 100,000  ̧ 12.00)]}

 

For purposes hereof, “Outstanding on a Fully
Diluted Basis” means, as of any date of determination, with
respect to the shares of Common Stock, (a) all shares of Company Common
Stock that are issued and outstanding on such date of determination, and (b) all
shares of Common Stock that would be outstanding as of such date of
determination assuming (i) the exercise of all then outstanding Options
(as defined below, and including, without limitation, the Warrants), (ii) the
conversion or exchange of all then outstanding Convertible Securities (as
defined below) and (iii) the conversion or exchange of all Convertible
Securities that would be outstanding after giving effect to the exercise of the
Options referred to in the foregoing clause (i) (in each case whether or
not such Options are at the time so exercisable and whether or not such Convertible
Securities are at the time so convertible or exchangeable).

 

For purposes of determining the number of
Warrant Shares pursuant to this Section 3.1, the following subsections (1) to
(9), inclusive, shall be applicable:

 

(1)                                  In
case the Company at any time shall in any manner grant (whether directly or by
assumption in a merger or otherwise) any rights to subscribe for or to
purchase, or any options for the purchase of, Common Stock or any stock or
other securities that are convertible into or exchangeable for Common Stock
(such rights or options being herein called “Options”
and such convertible or exchangeable stock or

 

4

 

securities being herein called “Convertible Securities”), whether or
not such Options or the right to convert or exchange any such Convertible
Securities are immediately exercisable, (A) for purposes of this Section 3.1,
the shares of Common Stock issuable upon exercise of such Options or upon
conversion or exchange of such Convertible Securities shall be deemed to be
issued upon the grant of such Options or the issuance of such Convertible
Securities, and (B) the Purchase Price with respect to such Options shall
be determined by dividing (x) the total amount, if any, received or receivable
by the Company as consideration for the granting of such Options, plus the
minimum aggregate amount of additional consideration payable to the Company
upon the exercise of all such Options, plus, in the case of such Options which
relate to Convertible Securities, the minimum aggregate amount of additional
consideration, if any, payable upon the issue or sale of such Convertible
Securities and upon the conversion or exchange thereof, by (y) the total
maximum number of shares of Common Stock issuable upon the exercise of such
Options or the conversion or exchange of such Convertible Securities.

 

(2)                                  In
case the Company at any time shall in any manner issue (whether directly or by
assumption in a merger or otherwise) or sell any Convertible Securities,
whether or not the rights to exchange or convert thereunder are immediately
exercisable, the Purchase Price of such Convertible Securities shall be
determined by dividing (x) the total amount received or receivable by the
Company as consideration for the issue or sale of such Convertible Securities,
plus the minimum aggregate amount of additional consideration, if any, payable
to the Company upon the conversion or exchange thereof, by (y) the total
maximum number of shares of Common Stock issuable upon the conversion or
exchange of all such Convertible Securities.

 

(3)                                  If
the purchase price provided for in any Options referred to in subsection (1),
the additional consideration, if any, payable upon the conversion or exchange
of any Convertible Securities referred to in subsections (1) or (2), or
the rate at which any Convertible Securities referred to in subsection (1) or
(2) are convertible into or exchangeable for Common Stock shall change at
any time, including by reason of provisions with respect thereto designed to
protect against dilution, the number of Warrant Shares in effect at the time of
such change shall forthwith be adjusted to the number of Warrant Shares which
would have been in effect at such time had such Options or Convertible
Securities outstanding at the time of such adjustment provided for such changed
purchase price, additional consideration or conversion rate, as the case may
be, at the time initially granted, issued or sold.

 

(4)                                  On
the expiration of any Option or the termination of any right to convert or
exchange any Convertible Securities, the number of Warrant Shares then in
effect hereunder shall forthwith be decreased to the number of Warrant Shares
which would have been in effect at the time of such expiration or termination
had such Option or Convertible Securities, to the extent outstanding
immediately prior to such expiration or termination, never been issued.

 

(5)                                  In
case any Options shall be issued in connection with the issue or sale of other
securities of the Company, together comprising one integral transaction in
which no specific consideration is allocated to such Options by the parties
thereto, such Options

 

5

 

shall be deemed to have been
issued without consideration.

 

(6)                                  In
case any shares of Common Stock, Options or Convertible Securities shall be
issued or sold or deemed to have been issued or sold for cash, the
consideration received therefor shall be deemed to be the amount received by
the Company therefor.  In case any shares
of Common Stock, Options or Convertible Securities shall be issued or sold for
a consideration other than cash, the amount of the consideration other than
cash received by the Company shall be the fair value of such consideration as
determined in good faith by the Board of Directors of the Company.  In case any shares of Common Stock, Options
or Convertible Securities shall be issued in connection with any merger in
which the Company is the surviving corporation, the amount of consideration therefor
shall be deemed to be the fair value of such portion of the net assets and
business of the non-surviving corporation as shall be attributed by the Board
of Directors of the Company in good faith to such Common Stock, Options or
Convertible Securities, as the case may be.

 

(7)                                  The
number of shares of Common Stock outstanding at any given time shall not
include shares owned or held by or for the account of the Company, and the
disposition of any shares so owned or held shall be considered an issue or sale
of Common Stock for the purpose of this Section 3.1.

 

(8)                                  In
case the Company shall declare a dividend or make any other distribution upon
the stock of the Company payable in Options or Convertible Securities, then in
such case any Options or Convertible Securities, as the case may be, issuable
in payment of such dividend or distribution shall be deemed to have been issued
or sold without consideration.

 

(9)                                  For
purposes of this Section 3.1, in case the Company shall take a record of
the holders of its Common Stock for the purpose of entitling them (x) to
receive a dividend or other distribution payable in Common Stock, Options or in
Convertible Securities, or (y) to subscribe for or purchase Common Stock,
Options or Convertible Securities, then such record date shall be deemed to be
the date of the issue or sale of the shares of Common Stock deemed to have been
issued or sold upon the declaration of such dividend or the making of such
other distribution or the date of the granting of such right or subscription or
purchase, as the case may be.

 

3.2                                 Dividends
Not Paid Out of Earnings or Earned Surplus. 
In the event the Company shall declare and pay a dividend upon the Common Stock
(other than a dividend payable in Common Stock) payable otherwise
than out of earnings or earned surplus, determined in accordance with generally
accepted accounting principles, including the making of appropriate deductions for minority
interests, if any, in subsidiaries (herein referred to as “Liquidating Dividends”), then, as
soon as possible after the exercise of this Warrant, the Company shall pay to
the Person exercising
this Warrant an amount equal to the aggregate value at the time of such
exercise of all Liquidating Dividends that it would have received if it had
exercised this Warrant and owned the underlying Warrant Shares immediately
prior to the record date for payment of such Liquidating Dividends, or, if no
such record date is taken, the date of payment thereof (including but not
limited to the Common Stock which would have been issued at the time of

 

6

 

such
earlier exercise and all other securities which would have been issued with
respect to such Common Stock by reason of
stock splits, stock dividends, mergers or reorganizations, or for any other
reason).  For the purposes of this Section 3.2,
a dividend other than in cash shall be considered payable out of earnings or
earned surplus only to the extent that such earnings or earned surplus are
charged an amount equal to the fair value of such dividend as determined in
good faith by the Board of Directors of the Company.

 

3.3                                 Subdivisions
and Combinations.  In case the
Company shall at any time (i) subdivide the outstanding Common Stock
or (ii) issue a stock dividend on its outstanding Common Stock,
the number of Warrant Shares in effect immediately prior to such subdivision or
dividend shall be proportionately increased by the same ratio as the subdivision or dividend.  In case the Company shall at any time combine
its outstanding Common Stock, the number of Warrant Shares in effect immediately prior to such
combination shall be proportionately decreased by the same ratio as the
combination.

 

3.4                                 Reorganization,
Reclassification, Consolidation, Merger or Sale of Assets.  If any capital reorganization or reclassification
of the capital stock of the Company, or consolidation or merger of the Company
with or into
another corporation, or the sale of all or substantially all of its assets to
another corporation shall be effected in such a way that holders of Common Stock shall be
entitled to receive stock, securities, cash or other property with respect to
or in exchange for Common Stock, then, as a
condition of such reorganization, reclassification, consolidation, merger or
sale, lawful and adequate provision shall be made whereby the Holder shall have
the right to acquire and receive, upon exercise of this Warrant, in lieu of
Warrant Shares, such shares of stock, securities, cash or other property
issuable or payable (as part  of the
reorganization, reclassification, consolidation, merger or sale) with respect
to or in exchange for such number of outstanding shares of the Common Stock as would have
been received upon exercise of this Warrant at the Exercise Price.  The Company will not effect any such
consolidation, merger or sale, unless prior to the consummation thereof the
successor corporation (if other than the Company) resulting from such
consolidation or merger or the corporation purchasing such assets shall assume
by written instrument mailed or delivered to the Holder at the last address of
the Holder appearing on the books of the Company, the obligation to deliver to
the Holder such shares of stock, securities or assets as, in accordance with
the foregoing provisions, the Holder may be entitled to receive.  If a purchase, tender or exchange offer is
made to and accepted by the holders of more than 50% of the outstanding shares
of Common Stock of the Company, the Company shall not effect any consolidation,
merger or sale with the Person having made such offer or with any Affiliate of
such Person, unless prior to the consummation of such consolidation, merger or
sale the Holder shall have been given a reasonable opportunity to then elect to
receive upon the exercise of this Warrant either the stock, securities or assets
then issuable with respect to the Common Stock or the stock,
securities or assets, or the equivalent, issued to previous holders of the Common Stock in accordance
with such offer.  For purposes hereof the
term “Affiliate” with respect to
any given Person shall mean any Person controlling, controlled by or under
common control with the given Person.

 

3.5                                 No
Adjustment for Exercise of Certain Options, 
Warrants, Etc.  The provisions
of this Section 3 shall not apply to any Common Stock issued, issuable or
deemed outstanding:

 

(1)                                  in
connection with any issuance of Warrants pursuant to the Stock

 

7

 

Purchase Agreement or the Note
Purchase Agreement or issuance of Common Stock pursuant to the exercise of
Warrants; or

 

(2)                                  with
respect to which the Holders shall have waived their rights to receive any such
adjustment.

 

3.6                                 Notices
of Record Date, Etc.  In the event
that:

 

(1)                                  the
Company shall declare any cash dividend upon its Common Stock,

 

(2)                                  the
Company shall declare any dividend upon its Common Stock payable in stock
or make any special dividend or other distribution to the holders of its Common Stock,

 

(3)                                  the
Company shall offer for subscription pro rata to the holders of its Common Stock any
additional shares of stock of any class or other rights,

 

(4)                                  there
shall be any capital reorganization or reclassification of the capital stock of
the Company, including any subdivision or combination of its outstanding shares
of Common
Stock, or consolidation or merger of the Company with, or sale
of all or substantially all of its assets to, another corporation, or

 

(5)                                  there
shall be a voluntary or involuntary dissolution, liquidation or winding up of
the Company;

 

then, in connection with such event, the
Company shall give to the Holder:

 

(a)                                  at
least twenty (20) days’ prior written notice of the date on which the books of
the Company shall close or a record shall be taken for such dividend,
distribution or subscription rights or for determining rights to vote in respect
of any such reorganization, reclassification, consolidation, merger, sale,
dissolution, liquidation or winding up; and

 

(b)                                 in
the case of any such reorganization, reclassification, consolidation, merger,
sale, dissolution, liquidation or winding up, at least twenty (20) days’ prior
written notice of the date when the same shall take place.

 

Such notice in accordance with the foregoing
clause (a) shall also specify, in the case of any such dividend,
distribution or subscription rights, the date on which the holders of Common Stock
shall be entitled thereto, and such notice in accordance with the foregoing
clause (b) shall also specify the date on which the holders of Common Stock
shall be entitled to exchange their Common Stock for securities or
other property deliverable upon such reorganization, reclassification
consolidation, merger, sale, dissolution, liquidation or winding up, as the
case may be.  Each such written notice
shall be given by first class mail, postage prepaid, addressed to the Holder at
the address of the Holder as shown on the books of the Company.

 

8

 

3.7                                 Grant,
Issue or Sale of Options, Convertible Securities, or Rights.  If at any time or from time to time on or
after the date of issuance hereof, the Company shall grant, issue or sell any
Options, Convertible Securities or rights to purchase shares of stock of the
Company of any class or series or other property (the “Purchase
Rights”) pro rata to the holders of any class of Common Stock or
any class or series of Options or Convertible Securities, and such grants,
issuances or sales do not result in an adjustment of the number of Warrant
Shares under Section 3.1 hereof, then the Holder shall be entitled to
acquire (within thirty (30) days after the later to occur of the initial
exercise date of such Purchase Rights or receipt by the Holder of the notice
concerning Purchase Rights to which the Holder shall be entitled under Section 3.6)
and upon the terms applicable to such Purchase Rights either:

 

(i)                                     the
aggregate Purchase Rights which the Holder could have acquired if it had held
the number of shares of Common Stock acquirable upon exercise of this Warrant
immediately before the grant, issuance or sale of such Purchase Rights;
provided that if any Purchase Rights were distributed to holders of Common
Stock without the payment of additional consideration by such holders,
corresponding Purchase Rights shall be distributed to the exercising Holder as
soon as possible after such exercise and it shall not be necessary for the
Holder specifically to request delivery of such rights; or

 

(ii)                                  in
the event that any such Purchase Rights shall have expired or shall expire
prior to the end of said thirty (30) day period, the number of shares of Common
Stock or the amount of property which the Holder could have acquired upon such
exercise at the time or times at which the Company granted, issued or sold such
expired Purchase Rights.

 

3.8                                 Fractional
Shares.  The Company shall not issue
fractions of shares of Common Stock upon exercise of this Warrant or scrip in
lieu thereof.  If any fraction of a share
of Common Stock
would, except for the provisions of this Section 3.8, be issuable upon exercise
of this Warrant, the Company shall in lieu thereof pay to the Person entitled
thereto an amount in cash equal to such fraction, calculated to the nearest one-hundredth
(1/100) of a share, multiplied by the Market Price for the Common Stock, determined
as of the date of exercise; provided, however, that if the Market
Price is to be determined by the Company and the Holder and the parties are
unable to reach agreement within 15 days after the date of such exercise, the
Market Price shall be promptly thereafter determined by the Company’s Board of
Directors in good faith rather than by an independent investment banking firm.

 

3.9                                 Adjustment
of Exercise Price.  Upon each
adjustment in the number of Warrant Shares purchasable under this Warrant
pursuant to any provision of this Section 3, the Exercise Price shall be
adjusted, to the nearest one hundredth of one cent, to the product obtained by
multiplying the Exercise Price in effect immediately prior to such adjustment
in the number of Warrant Shares by a fraction, the numerator of which shall be
the number of Warrant Shares purchasable under this Warrant immediately prior
to such adjustment and the denominator of which shall be the number of Warrant
Shares purchasable under this Warrant immediately after giving effect to such
adjustment.  If the Company shall be in
default under any provision contained in Section 4 of this Warrant so that
shares issued at the Exercise Price adjusted in accordance with this Section 3
would not be validly issued, the adjustment of number of shares provided for in
the foregoing sentence shall nonetheless be made and the Holder of this Warrant

 

9

 

shall be entitled to purchase such greater number of shares at the
lowest price at which such shares may then be validly issued under applicable
law.  Such exercise shall not constitute
a waiver of any claim arising against the Company by reason of its default
under Section 4 of this Warrant.

 

3.10                           Officers’
Statement as to Adjustments. 
Whenever the number of Warrant Shares and the Exercise Price shall be
adjusted as provided in Section 3 hereof, the Company shall forthwith prepare and
thereafter maintain at the Company’s office a statement signed by the Chairman
of the Board, the President, any Vice President or Treasurer of the Company,
showing in reasonable detail the facts requiring such adjustment, the method by
which such adjustment was calculated and the number of Warrant Shares and the
Exercise Price that will be effective after such adjustment.  The Company shall also cause a notice setting
forth any such adjustments to be sent by mail, first class, postage prepaid, to
the record Holder at his or its address appearing on the stock register.

 

4.                                       NO DILUTION
OR IMPAIRMENT.  The Company will not, by amendment of its
Certificate of Incorporation or through reorganization, consolidation, merger,
dissolution, sale of assets or any other voluntary action, avoid or seek to
avoid the observance or performance of any of the terms of this Warrant, but
will at all times in good faith assist in the carrying out of all such terms
and in the taking of all such action as may be necessary or appropriate in
order to protect the rights of the Holder set forth herein.  Without limiting the generality of the
foregoing, the Company will not increase the par value of any shares of stock
receivable upon the exercise of this Warrant above the amount payable therefor
upon such exercise, and at all times will take all such action as may be
necessary or appropriate in order that the Company may validly and legally
issue fully paid and non-assessable stock upon the exercise of this Warrant.

 

5.                                       RESERVATION
OF STOCK, ETC., ISSUABLE ON EXERCISE OF WARRANTS.  The
Company shall at all times reserve and keep available out of its
authorized but unissued stock, solely for the issuance and delivery upon the
exercise of this Warrant, such number of its duly authorized shares of Common Stock as from time to time shall be issuable upon the exercise of this
Warrant.

 

6.                                       REMEDIES.  The Company stipulates that the remedies at law of the Holder in the event of any
default by the Company in the performance of or compliance with any of the
terms of this Warrant are not and will not be adequate, and that the same may
be specifically enforced.

 

7.                                       TRANSFER, ETC.

 

7.1                                 Ownership
of Warrant.  The Company may deem and
treat the person in whose name this Warrant is registered as the holder and the
owner hereof, notwithstanding any notations of ownership or writing hereon made
by anyone other than the Company, for all purposes and shall not be affected by
any notice to the contrary, until presentation of this Warrant for registration
or transfer as provided in Section 7.2. 
The Company shall maintain, at the Principal Office, a register for the
Warrants, in which the Company shall record the name and address of the person
in whose name each Warrant has been issued, as well as the name and address of
each transferee and each prior owner of such Warrant.

 

10

 

7.2                                 Exchange,
Transfer and Replacement.  This
Warrant is exchangeable, upon the surrender hereof by the registered Holder to
the Company at its Principal Office, for new Warrants of like tenor,
representing in the aggregate the right to purchase the number of Warrant
Shares purchasable hereunder, each of such new Warrants to represent the right
to purchase such number of Warrant Shares as shall be designated by said
registered Holder at the time of such surrender.  This Warrant and all rights hereunder are
transferable, in whole or in part, only upon the register provided for in Section 7.1,
by the registered Holder hereof in person or by duly authorized attorney, and a
new Warrant shall be made and delivered by the Company, of the same tenor as
this Warrant but registered in the name of the transferee, upon surrender of
this Warrant with the Assignment Form attached hereto duly completed, at
said office or agency of the Company. 
Upon receipt by the Company at its Principal Office of evidence
reasonably satisfactory to it of the loss, theft, destruction or mutilation of
this Warrant, and, in the case of loss, theft or destruction, of indemnity or
security reasonably satisfactory to it and upon surrender there of this
Warrant, if mutilated, the Company will make and deliver a new Warrant of like
tenor in replacement of this Warrant. 
This Warrant shall be promptly cancelled by the Company upon the
surrender hereof in connection with any exchange, transfer or replacement.  The Company shall pay all expenses and
charges (other than securities transfer taxes) payable in connection with the
preparation, execution and delivery of Warrants pursuant to this Section 7.2.

 

7.3                                 Rights
of Holder.  Prior to the exercise of
this Warrant, the Holder shall not be entitled to any rights of a shareholder
of the Company with respect to Warrant shares for which this Warrant shall be
exercisable, including, without limitation, the right to vote, to receive
dividends or other distributions or to exercise any preemptive rights, and
shall not be entitled to receive any notice of any proceedings of the Company,
except as provided herein.

 

7.4                                 Transfer
Taxes.  The Company shall not be
required to pay any Federal or state transfer tax or charge that may be payable
in respect of any transfer involved in the transfer or delivery of this Warrant
or the issuance or conversion or delivery of certificates for Warrant Shares in
a name other than that of the registered Holder or to issue or deliver any
certificates for Warrant Shares upon the exercise of this Warrant until
any and all such taxes and charges shall have been paid by the Holder or until
it has been established to the Company’s satisfaction that no such tax or
charge is due.

 

8.                                       REDEMPTION OF
WARRANT.

 

8.1                                 Right
to Redeem.  If, on or before the
Expiration Date, (i) the Holder has not exercised this Warrant in whole
and (ii) the Company has not completed a Qualified IPO (as defined below),
then the Holder, upon the written consent of the Majority Holders, may elect to
require the Company to redeem this Warrant for an amount in cash equal to the
price determined pursuant to Section 8.2 below (the “Warrant
Redemption Price”). 
During the 10-day period prior to the Expiration Date, the Holder shall
deliver written notice to the Company of its election to exercise its rights
under this Section 8 (such notice to be accompanied by this Warrant, or if
this Warrant has been lost or stolen, an affidavit evidencing such loss).  For the purposes of this Section 8, a “Qualified IPO” shall mean the
Company’s initial underwritten public offering of Common Stock for cash
pursuant to an effective registration statement under the Securities Act in
which the aggregate net cash proceeds to the Company are not less than $10,000,000,
and which is effected by means of a firm commitment underwriting managed by

 

11

 

one or more managing underwriters that are nationally recognized
investment banking firms reasonably acceptable to the Majority Holders.

 

8.2                                 Redemption
Price.  The Warrant Redemption Price
shall be equal to the product of (i) the Market Price per share of Common
Stock as of the Expiration Date, less the Exercise Price per share, multiplied
by (ii) the number of Warrant Shares at the time in effect.

 

8.3                                 Payment
of Redemption Price.  Within five (5) Business
Days after the Expiration Date, or in the event of any dispute with respect to
determination of the Market Price of the Common Stock, within five (5) Business
Days after the resolution of such dispute as provided in the definition of “Market
Price” herein, the Company shall pay the Warrant Redemption Price via wire
transfer of immediately available funds to such account as the Holder shall
designate in writing.

 

9.                                       CALL RIGHTS OF COMPANY.  The rights of the Holder of this Warrant are
subject to the provisions of Section 2.7 of the Stock Purchase Agreement.

 

10.                                 MAILING OF
NOTICES, ETC.  All notices and other communications from the
Company to the Holder shall be mailed by first-class certified mail, postage
prepaid, to the address furnished to the Company in writing by the last Holder
of this Warrant who shall have furnished an address to the
Company in writing.

 

11.                                 HEADINGS,
ETC.  The headings in this Warrant are for purposes
of reference only, and shall not limit or otherwise affect the meaning hereof.

 

12.                                 CHANGE,
WAIVER, ETC.  Neither this Warrant nor any term hereof may
be changed, waived, discharged or terminated orally but only
by an instrument in writing signed by the party against which enforcement of
the change, waiver, discharge or termination is sought.

 

13.                               GOVERNING LAW.  THIS WARRANT
SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW
YORK, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES.

 

[Signature Page Follows]

 

12

 

IN WITNESS
WHEREOF, the Issuer has executed this Warrant by its officer thereunto duly
authorized.

 

	
   

  	
  GENUTEC
  BUSINESS SOLUTIONS, INC.

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Lee Danna

  	
   

  
	
   

  	
   

  	
  Name:

  	
  Lee J. Danna

  
	
   

  	
   

  	
  Title:

  	
  President/C.E.O.

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Dated: November 16, 2005

  	
   

  	
   

  
					

 

13

 

[To be
signed only upon exercise of Warrant]

 

EXERCISE NOTICE

 

GenuTec Business Solutions, Inc.

6A Liberty
Street, Suite 200

Aliso Viejo,
CA  92656

Attention:  

 

Pursuant to
the provisions of the Warrant to purchase shares of Class A Voting Common Stock,
par value $.01 per share, issued by GenuTec Business Solutions, Inc. and
held by the undersigned, the original of which is delivered herewith, the
undersigned hereby elects to purchase          
such shares, and (check the applicable box):

 

 ̈                                    Tenders
herewith payment of the Exercise Payment (as defined in the Warrant) in full in
the form of cash, certified check or official bank check in the amount of $                  
for                
such securities.

 

 ̈                                    Confirms
that payment of the Exercise Payment in full by means of a wire transfer in the
amount of $                  
for                
such securities has been made to the Company.

 

 ̈                                    Elects
to surrender to the Company for cancellation securities of the Company having a
Market Price (as defined in the Warrant) on the date hereof equal to the
Exercise Payment.

 

 ̈                                    Elects to exercise
the Warrant by Cashless Exercise (as defined in the Warrant).

 

The
undersigned hereby represents and warrants that the undersigned is
acquiring such shares for its own account for investment purposes only, and not
for resale or with a view to distribution of such shares or any part thereof.

 

The undersigned requests that the
certificates for such shares be issued in the name of, and be delivered to                       ,
whose address is                     .

 

	
  Dated:

  	
   

  	
  , 20

  	
   

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  (Signature must conform in all

  respects to name of Holder as

  specified on the face of the

  Warrant)

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Address

  	
   

  

 

 

[To be
signed only upon transfer of Warrant]

 

ASSIGNMENT
FORM

 

FOR VALUE RECEIVED, the undersigned hereby
sells, assigns and transfers unto                             
the right represented by the within Warrant to purchase                   
shares of the Class A Voting Common Stock, par value $.01
per share, of GenuTec
Business Solutions, Inc. to which the within Warrant relates, and
appoints                     
attorney to transfer said right on the books of GenuTec Business Solutions, Inc., with full power of
substitution in the premises.

 

	
  Dated:

  	
   

  	
  , 20

  	
   

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  (Signature must conform in all

  respects to name of Holder as

  specified on the face of the

  Warrant)

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Address

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}]]